rs137852356
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000132.4(F8):c.6403C>T(p.Arg2135*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000132.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:2
PM2, PS4_Moderate, PVS1 -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 24602271, 20331753, 3097553, 33706050, 29381227, 32897612, 35014236, 29296726) -
Hereditary factor VIII deficiency disease Pathogenic:2
The F8 c.6403C>T; p.Arg2135Ter variant (rs137852356), also known as Arg2116Ter, has been reported in multiple patients diagnosed with severe hemophilia A (see link to Factor VIII database, Higuchi 1989, Jayandharan 2009, Millar 1991, Tavasolli 1997, Wang 2010, Yousouffian 1986). This variant is also reported in ClinVar (Variation ID: 10088), but is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Factor VIII variant database: http://www.factorviii-db.org/advance_search_results.php?dosearch=1&codon=2135 Higuchi M et al. Molecular defects in hemophilia A: identification and characterization of mutations in the factor VIII gene and family analysis. Blood. 1989 Aug 15;74(3):1045-51. PMID: 2473810. Jayandharan G et al.Polymorphism in factor VII gene modifies phenotype of severe haemophilia. Haemophilia. 2009 Nov;15(6):1228-36. PMID: 19686262. Millar D et al. The molecular genetics of haemophilia A: screening for point mutations in the factor VIII gene using the restriction enzyme TaqI. Hum Genet. 1991 Sep;87(5):607-12. PMID: 1840568. Tavassoli K et al. Mutational analysis of ectopic factor VIII transcripts from hemophilia A patients: identification of cryptic splice site, exon skipping and novel point mutations. Hum Genet. 1997 Oct;100(5-6):508-11. PMID: 9341862. Wang X et al. The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A. Haemophilia. 2010 Jul 1;16(4):632-9. PMID: 20331753. Youssoufian H et al. Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature. 1986 Nov 27-Dec 3;324(6095):380-2. PMID: 3097553. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at